Mary Robinson

Technical Director
Laboratory Corporation of America Holdings

Presentation(s):

• PB0991 - Assessment of Interference by Emicizumab in the Measurement of Susoctocog Alfa Factor VIII Activity Using a Chromogenic Assay

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM